De Novo Non-Alcoholic Fatty Liver Disease Following Orthotopic Liver Transplantation (Q44606344)

4 December 2017

De novo non-alcoholic fatty liver disease following orthotopic liver transplantation (English)

1 reference

4 December 2017

De Novo Non-Alcoholic Fatty Liver Disease Following Orthotopic Liver Transplantation (English)

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

orthotopic liver transplantation

17 March 2024

main subject

liver transplantation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

1

Fred Poordad

0 references

Robert Gish

2

object named as

Robert Gish

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14525603

17 March 2024

author name string

Adil Wakil

3

1 reference

4 December 2017

Richard Garcia-Kennedy

4

1 reference

4 December 2017

Paul Martin

5

1 reference

4 December 2017

Francis Y. Yao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14525603

17 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

4 December 2017

http://www.amjtransplant.org/article/S1600613522074068/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14525603

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1600-6143.2003.00203.x

17 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

https://api.elsevier.com/content/article/PII:S1600613522074068?httpAccept=text/xml

17 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

https://api.elsevier.com/content/article/PII:S1600613522074068?httpAccept=text/plain

17 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1600-6143.2003.00203.x/fullpdf

17 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

American Journal of Transplantation

17 March 2024

published in

1 reference

4 December 2017

3

1 reference

4 December 2017

1413-1417

1 reference

4 December 2017

11

1 reference

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

4 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00203.X

Nonalcoholic Steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00203.X

Amiodarone hepatotoxicity. A clinicopathologic study of five patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00203.X

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00203.X

Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00203.X

A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00203.X

Histologic progression of recurrent hepatitis C in liver transplant allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00203.X

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00203.X

Mitochondria in steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00203.X

Reduction in hepatic cytochrome P-450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00203.X

Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00203.X

Steatohepatitis associated with limb lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00203.X

Nonalcoholic steatohepatitis: an expanded clinical entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00203.X

Recurrence of nonalcoholic steatohepatitis following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00203.X

Dietary carbohydrate intake plays an important role in preventing alcoholic fatty liver in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00203.X

Liver fibrosis in overweight patients

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study

17 March 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

17 March 2024

6

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

17 March 2024

7

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

17 March 2024

9

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

Liver histology abnormalities in the morbidly obese

17 March 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

Effect on Hepatic Morphology of Treatment of Obesity by Fasting, Reducing Diets and Small-Bowel Bypass

17 March 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

Protein nutrition and liver disease after jejunoileal bypass for morbid obesity

17 March 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

Hepatic complications of parenteral nutrition

17 March 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies

17 March 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

"Nonalcoholic steatohepatitis" induced by massive doses of synthetic estrogen

17 March 2024

19

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis

17 March 2024

25

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation

17 March 2024

27

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient.

17 March 2024

28

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation

17 March 2024

30

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report

17 March 2024

32

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

Histopathology of hepatitis C virus infection

17 March 2024

34

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study

17 March 2024

36

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth

17 March 2024

39

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

Mitochondrial energy synthesis during cold preservation and after reperfusion in liver transplantation

17 March 2024

40

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

Fragility of the electron transport chain and superoxide generation in mitochondria of the liver graft after cold ischemia

17 March 2024

41

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis

17 March 2024

43

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00203.X

17 March 2024

Identifiers

1 reference

4 December 2017

1 reference